Misbah Tahir
Finanzdirektor/CFO bei IGM BIOSCIENCES, INC.
Vermögen: 691 698 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Misbah Tahir
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 28 | |
| Public Company | Pharmaceuticals: Major | 26 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Misbah Tahir
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| Washington University in St. Louis | College/University | Doctorate Degree Undergraduate Degree | |
| ACCELRYS, INC. | Packaged Software | Sales & Marketing | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| SEQUENOM, INC. | Medical Specialties | Public Communications Contact | |
| CHIMERIX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Baker Bros. Advisors LP
 Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Investment Managers | Founder Portfolio Manager-Equities | |
| CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Graduate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| UCB | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal | |
| AFFYMAX, INC. | Biotechnology | General Counsel Human Resources Officer | |
GCA Law Partners LLP
 GCA Law Partners LLP Miscellaneous Commercial ServicesCommercial Services GCA Law Partners LLP is based in Mountain View, CA. GCA Law Partners LLP is a law firm that has been providing legal services to the business community since 1988. The company was founded by Fred M. Schwarzer. | Miscellaneous Commercial Services | Founder Corporate Officer/Principal | |
| The University of Texas at Austin | College/University | Doctorate Degree Undergraduate Degree | |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Corporate Officer/Principal Doctorate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree Corporate Officer/Principal | |
Haldor Topsøe A/S
 Haldor Topsøe A/S Chemicals: SpecialtyProcess Industries Haldor Topsoe A/S manufactures and supplies catalysts and proprietary technology for chemical and refining industries. The company was founded by Haldor Frederik Topsøe in 1940 and is headquartered in Kongens Lyngby, Denmark. | Chemicals: Specialty | Director/Board Member Director/Board Member | |
| PDL BIOPHARMA, INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
| NEVRO CORP. | Medical Specialties | Human Resources Officer Human Resources Officer | |
Minimally Invasive Devices, Inc.
 Minimally Invasive Devices, Inc. Medical SpecialtiesHealth Technology Minimally Invasive Devices, Inc. develops laparoscopic visualization tools and systems. It offers FloShield Air, a vortex barrier technology that provides a continuous flow of dry carbon dioxide gas over the tip of the scope, instantly defogging it while continuously shielding it from condensation, debris, and smoke. It also offers FloShield Plus, an intra-operative flush that can be used to clean a scope if it gets dirty during surgery. The company was founded by Wayne L. Poll and Jodi Wolfe in 2006 and is headquartered in Columbus, OH. | Medical Specialties | Director/Board Member Chairman | |
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| CLOVIS ONCOLOGY, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Topsøe Holding A/S
 Topsøe Holding A/S Financial ConglomeratesFinance Haldor Topsøe Holding A/S operates as a holding company with interests in manufacturing of industrial catalysts. It provides catalysts for the production of ammonia, hydrogen, synthesis gas, methanol, and sulfuric acid. The firm offers services to the refining, gas synthesis and processing, power, automotive, metallurgical, chemical, pharmaceutical and the rubber industries. The company was founded by Haldor Frederik Aksel Topsøe on September 14, 2007 and is headquartered in Kongens Lyngby, Denmark. | Financial Conglomerates | Chairman Director/Board Member | |
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| Tufts University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| Case Western Reserve University School of Medicine | College/University | Doctorate Degree | |
| IDEAYA BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Fourier Biotechnologies LLC | Founder | ||
Accent Therapeutics, Inc.
 Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | Biotechnology | Director/Board Member | |
| NEUMORA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal President Corporate Officer/Principal | |
| ICOSAVAX, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Onc.ai, Inc.
 Onc.ai, Inc. Packaged SoftwareTechnology Services Onc.ai, Inc. is a digital health company that is privately held and is developing a precision oncology care management platform. The company is based in San Carlos, CA. The company aims to transform clinical decision making and is backed by premier investment firms such as the Blue Venture Fund, MassMutual Alternative Investments, and Accomplice, among others. The company is building a pipeline of physician-centered products to fulfill the potential of precision oncology. The company was founded by Akshay Nanduri, who has been the CEO since incorporation. | Packaged Software | Director/Board Member | |
Gennao Bio, Inc.
 Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Gennao Bio, Inc. is a privately-held genetic medicines company that is developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing its proprietary gene monoclonal antibody (gmab) platform technology. The company is based in Pennington, NJ. The company's gmab technology uses a novel, cell-penetrating antibody to non-covalently bind to, and deliver therapeutic levels of a wide variety of nucleic acid payloads, to select cells. Gennao Bio is initially focusing on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases. The company's non-viral delivery platform offers significant advantages over traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and dose optimization, and can be easily and affordably manufactured. The company was founded in 2020 by Bruce Turner, Elias Quijano, Peter M. Glazer, Stephen P. Squinto. Christopher M. Duke has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
| ERASCA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ARIDIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Simpson Interventions , Inc. | Founder |
Statistik
International
| Vereinigte Staaten | 45 |
| Dänemark | 4 |
| Kanada | 3 |
| Belgien | 2 |
Sektoral
| Health Technology | 29 |
| Consumer Services | 12 |
| Finance | 4 |
| Commercial Services | 4 |
| Technology Services | 3 |
Operativ
| Director/Board Member | 185 |
| Corporate Officer/Principal | 99 |
| Independent Dir/Board Member | 71 |
| Undergraduate Degree | 46 |
| Chairman | 32 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Mark McDade | 35 |
| William Ringo | 32 |
| Wende Hutton | 31 |
| Felix Baker | 28 |
| David Cohen | 20 |
| Kathleen Sebelius | 18 |
| Fred Schwarzer | 17 |
| Matthew Fust | 16 |
| Julie Hambleton | 15 |
| Andrew Guggenhime | 13 |
| Michael Loberg | 13 |
| Kelvin Neu | 13 |
| M. Wilsey | 13 |
| Lori Lyons-Williams | 11 |
| Ian Clements | 11 |
- Börse
- Insiders
- Misbah Tahir
- Unternehmensverbindungen
